my feeling is that SOO will now attract more of a long term investor who would appreciate it's potential for sustained growth.DYE on the other hand is likely to attract the momentum traders for the time being.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come